Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-006836
Filing Date
2020-03-19
Accepted
2020-03-19 12:21:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ea119642-f1a1_therapixbio.htm F-1/A 1526059
2 FORM OF SECURITIES PURCHASE AGREEMENT ea119642ex4-7_therapixbio.htm EX-4.7 193493
3 FORM OF PRE-FUNDED WARRANT ea119642ex4-8_therapixbio.htm EX-4.8 94659
4 FORM OF SERIES B WARRANT ea119642ex4-9_therapixbio.htm EX-4.9 123938
5 CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL ea119642ex23-1_therapixbio.htm EX-23.1 4458
6 GRAPHIC image_001.jpg GRAPHIC 29197
7 GRAPHIC image_002.jpg GRAPHIC 2276
  Complete submission text file 0001213900-20-006836.txt   1987268
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236175 | Film No.: 20727327
SIC: 2834 Pharmaceutical Preparations